Flaxseed Lignan Complex Administration in Older Human Type 2 Diabetics Manages Central Obesity and Prothrombosis—An Invitation to Further Investigation into Polypharmacy Reduction

Flaxseed Lignan Complex Administration in Older Human Type 2 Diabetics Manages Central Obesity and Prothrombosis—An Invitation to Further Investigation into Polypharmacy Reduction

Aim. Animal and human study evidence supports the hypothesis that flaxseed lignan complex (FLC) at a dose of 600 mg secoisolariciresinol diglucoside (SDG)/day for three months would combat hyperglycaemia, dyslipidemia, blood pressure, central obesity, prothrombotic state, inflammation, and low densi...

Full description

Saved in:
Bibliographic Details
Main Authors: D. E. Barre, K. A. Mizier-Barre, E. Stelmach, J. Hobson, O. Griscti, A. Rudiuk, D. Muthuthevar
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2012/585170
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items